1.232
price down icon0.35%   -0.008
 
loading

Finanzdaten der Ocugen Inc-Aktie (OCGN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
7.29%
1.373
1.481 0.764 1.136 1.141
Operating Expenses
5.09%
15.17
15.98 14.60 14.39 16.59
Benefits Costs and Expenses
-
- 58.11 - -
Costs And Expenses
5.09%
15.17
15.98 13.90 14.39 16.59
Operating Income/Loss
4.87%
-13.79
-14.50 -13.84 -13.25 -15.45
Nonoperating Income/Loss
75.38%
0.114
0.065 -0.04 0.282 0.169
Income/Loss From Continuing Operations Before Tax
108.94%
1.373
-15.35 -57.34 1.136 -15.28
Income/Loss From Continuing Operations After Tax
3.98%
-14.74
-15.35 -13.88 -12.97 -15.28
Net Income/Loss
3.98%
-14.74
-15.35 -13.88 -12.97 -15.28
Preferred Stock Dividends And Other Adjustments
-
- - - -4.988
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.09
price down icon 0.50%
$30.14
price down icon 0.23%
$104.22
price down icon 0.78%
$102.73
price down icon 1.14%
biotechnology ONC
$364.93
price down icon 1.08%
$190.04
price down icon 1.55%
Kapitalisierung:     |  Volumen (24h):